Emphysema Symptoms

Emphysema Symptoms

What is Emphysema?

The average person breathes in life-sustaining oxygen nearly 25,000 times per day, but for people with lung diseases this simple bodily function is a constant effort. One such lung disease is emphysema. Emphysema is one of the major obstructive lung diseases encompassed by the term chronic obstructive pulmonary disease (COPD). Emphysema consists of the gradual destruction of the air sacs clustered like tiny grapes in the lungs, known as alveoli, resulting in increasing difficulty breathing. The alveoli are responsible for delivering oxygen to the bloodstream. As emphysema progresses, the inner walls of the alveoli are compromised, weakening their internal structure and hindering the delivery of oxygen to the bloodstream. Emphysema not only destroys the alveoli, it gradually destroys the elasticity of the airways leading to them. Shortness of breath and the constant struggle for air are familiar to emphysema sufferers.

Emphysema Symptoms

There are a number of conditions classified as lung disease, and the symptoms and causes vary. Here are some of the most common symptoms found to be associated with emphysema:

  • Severe or chronic coughing
  • Shortness of breath
  • Recurring infections
  • Fatigue
  • Excess production of mucus in the lungs
  • Wheezing

Despite being currently incurable, emphysema can be treated. The first recommendation by any pulmonary physician is to advise individuals to stop smoking and stay away from smoke-filled locations. Many physicians also prescribe a combination of bronchodilators and steroids to help expand the airways, thus allowing more airflow to and from the lungs and reducing shortness of breath. Emphysema is also commonly treated with a series of pulmonary rehabilitation (aerobic exercise) and nutritional support. For people in the most severe stages of emphysema, supplemental oxygen is also used for treatment—ranging from occasional use to 24/7 use. In severe cases, a physician may suggest a lung transplant, but transplant opportunities are usually limited, and eligibility requirements are challenging. No currently available treatment improves lung function, but new, innovative treatment is now available to slow, or even halt the progression of the disease.

Cell Therapy for Emphysema

Autologous stem cells–that is, cells derived from the patient’s own body and found in adult blood or bone marrow, have the capacity to differentiate into many types of specialized cells. Cell treatment involves isolating adult stem cells from bone marrow blood tissue in the laboratory. After extraction of the cells from the patient’s body, they are isolated and reintroduced to the patient intravenously. The treatment is a minimally invasive and typically an outpatient procedure performed in a clinical setting under the supervision of medical professionals.

If you would like to find out more about finding relief for symptoms of emphysema, please contact one of our patient care coordinators today at (800) 729-3065 to schedule a free consultation.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.